Status | Study |
Recruiting |
Study Name: CREATE: Cross-tumoral Phase 2 With Crizotinib Condition: Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma Locally Advanced and/or Me Date: 2012-01-24 Interventions: Drug: Crizotinib (PF-02341066) For patients of 15yo and older, Capsules of 200 and 250 mg Daily dose of |
Completed |
Study Name: A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC) Condition: Carcinoma, Renal Cell Date: 2008-07-29 Interventions: Drug: foretinib (formerly GSK1363089 or XL880) treatment with oral foretinib on one of 2 dosing regimens |
Terminated |
Study Name: Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer Condition: Kidney Cancer Date: 2008-01-22 Interventions: Biological: bevacizumab 15 mg/kg over 90 minutes every 3 weeks |
Terminated |
Study Name: Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer Condition: Kidney Cancer Date: 2007-10-05 Interventions: Drug: sunitinib malate |
Completed |
Study Name: Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer Condition: Kidney Cancer Date: 2007-04-11 Interventions: Drug: sunitinib malate |
Completed |
Study Name: Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery Condition: Kidney Cancer Date: 2007-04-11 Interventions: Drug: sunitinib malate Sunitin |
Completed |
Study Name: Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer Condition: Kidney Cancer Date: 2006-11-16 Interventions: Drug: gemcitabine hydrochloride Drug: irin |
Completed |
Study Name: Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Condition: Childhood Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma Date: 2006-06-08 Interventions: Drug: Doxorubicin Hydrochloride |
Terminated |
Study Name: Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer Condition: Kidney Cancer Date: 2006-05-08 Interventions: Drug: gemcitabine hydrochloride Drug: imat |
Completed |
Study Name: Bortezomib in Treating Patients With Metastatic Kidney Cancer Condition: Kidney Cancer Date: 2006-01-12 Interventions: Drug: bortezomib |